Łukasz Tanajewski

Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service

Rachel Elliott, Matthew Boyd, Nde-Eshimuni Salema et al. · BMJ Quality & Safety · 2015 · 106 citations · Full text

Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study

Łukasz Tanajewski, Rebecca Harris, D. J. Harman et al. · BMJ Open · 2017 · 66 citations · Full text

Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice

Rachel Elliott, Łukasz Tanajewski, Georgios Gkountouras et al. · PharmacoEconomics · 2017 · 58 citations · Full text

‘New Medicine Service’: supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trial

Rachel Elliott, Matthew Boyd, Łukasz Tanajewski et al. · BMJ Quality & Safety · 2019 · 46 citations · Full text

NHS Outcomes Framework 2012–13

John Gladman, Rowan Harwood, Simon Conroy et al. · 2015 · 43 citations

Health Systems, Primary Care, Health Policy +8